News & Events

Culturing cells in 3D has proven to be a relevant approach for basic research and drug development. Many tumor cells and primary cells can be grown in 3D as spheroids. Corning wants to bring together researchers who are working with these spheroids or epithelial organoids to exchange ideas, learn from each other, and extend networks.

This meeting will discuss the ongoing research projects at the Adolphe Merkle Institute (AMI). AMI focuses on research and education in the domain of soft nanomaterials. They are investigating how tissue engineering approaches can be optimized to improve the predictive power of human 3D models.

Life Sciences Switzerland (LS²) is organizing its annual event for scientists in different research areas from all nations and backgrounds. It is coordinated with the German Society for Biochemistry and Molecular Biology (GBM) and the Austrian Association of Molecular Life Sciences and Biotechnology (ÖGMBT).The symposium is accredited for continuous education in the field of animal experimentation.

VIB is organizing its third edition on bioinformatics. (Intern-)national speakers will present their latest findings in applied bioinformatics in medical, agricultural, and biotechnological research.

Plenary sessions include:

• Microbial and plant genomics: from simple to complex
• Proteomics Structural and Bioinformatics
• Data integration, machine learning and networks
• Single Cell Bioinformatics

During this symposium scientists from different research areas will discuss the progress they have made on the molecular and genetic understanding of whole-organism physiology.

This practical course is tailored for PhD students and early PostDocs with prior expertise in one (or more) of the “omes”, and who are planning to perform multi-omics studies of microbiota.Through hands-on training, participants will have the opportunity to immediately apply the newly gained knowledge on different topics and techniques.

The aim of this conference is to close the gap in translational immunopathology. Clinicians, research scientists and industry partners are brought together to debate on the progress from bench to bedside.

The focus will be on precision medicine, starting from disease-oriented cases to lessons learned. Innovative and alternative therapeutic strategies in immune-mediated disorders will be presented, besides the regulatory challenges that companies and researchers are dealing with.

During this 6-days course, participants will take part in a series of lectures and group exercises focused on applied in vitro toxicology with real life case studies on how to incorporate data from in vitro test methods into regulatory safety evaluation of chemicals. Moreover, they will gain hands-on experience in skin and eye irritation testing in vitro as well as gastro-intestinal testing in vitro.